Meta Lipoate300
This product has been discontinued. Label data shown is from the last available version.
Product Information
- Brand
- Metagenics
- Form
- Tablet or Pill
- Servings Per Container
- 60
- UPC
- 7 55571 91063 9
- Product Type
- Non-Nutrient/Non-Botanical
- DSLD Entry Date
- 2013-12-24
Target Groups
Label Statements
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Brand IP Statement(s) re: (c), (TM), (SM)
Meta Lipoate(R) 300 features an enhanced level of high quality alpha-lipoic acid (ALA) for convenient, one-tablet dosage.
Formulation re: Vegetarian/Vegan
Vegetarian
Storage
STORAGE: Keep tightly closed in a cool, dry place.
FDA Statement of Identity
Dietary Supplement
General Statements: All Other Content
ALA may protect tissues from free radicals, enhance glucose transport and metabolism, support nerve tissue health (especially peripheral nerves), enhance the production of cellular energy (ATP), and support liver health and detoxification. ALA has broad antioxidant activity in both aqueous and fatty tissues. It not only scavenges free radicals, but also recycles other antioxidants-factors contributing to many of its benefits.
Suggested/Recommended/Usage/Directions
DIRECTIONS: Take one tablet daily or as directed by your healthcare practitioner.
Formulation re: Does NOT Contain
Formulated to Exclude: Wheat, gluten, corn, soy, animal or dairy products, nuts, tree nuts, fish, crustacean shellfish, colors, artificial sweeteners, and preservatives.
General Statements: All Other Content
Genetic Potential Through Nutrition
Formula re: Contains
High Quality Alpha-Lipoic Acid
General Statements: All Other Content
LME043F2
General Statements: All Other Content
LOT# 0510026 EXP: 05/12
General Statements: All Other Content
PROD. METL3
Supplement Facts Panel
* Percent Daily Values are based on a 2,000 calorie diet.
† Daily Value not established.